CTNM
NASDAQ
US
Contineum Therapeutics, Inc. - Common stock
$13.44
▼ $-0.01
(-0.07%)
Vol 111K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$417.5M
ROE
-16.2%
D/E
0.00
Beta
-0.14
52W
$3–$15
Wall Street Consensus
13 analysts · Apr 20266
Strong Buy
5
Buy
2
Hold
0
Sell
0
Strong Sell
84.6%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%
Next Report
May 12, 2026
EPS Estimate: $-0.54
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.54 | — | — |
| Dec 2025 | $-0.41 | $-0.49 | $-0.08 |
| Sep 2025 | $-0.49 | $-0.45 | +$0.04 |
| Jun 2025 | $-0.45 | $-0.62 | $-0.17 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$14.6M | -$16.0M | -$16.0M | -$12.8M | -$15.2M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -16.2% | -16.2% | -16.2% | -16.2% | -16.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 24.51 | 24.51 | 24.51 | 24.51 | 29.07 | 29.07 |
Key Ratios
ROA (TTM)
-15.6%
P/B
1.9
EPS (TTM)
$-1.31
52W High
$15.25
52W Low
$3.35
$3.35
52-Week Range
$15.25
Financial Health
Free Cash Flow
-$13.1M
Net Debt
-$67.4M
Cash
$75.6M
Total Debt
$8.2M
As of Dec 31, 2025
How does CTNM compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
CTNM valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.9
▼
10%
below
peers
(2.1)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
CTNM profitability vs Pharmaceuticals peers
ROE
-16.2%
▲
70%
above
peers
(-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-15.6%
▲
58%
above
peers
(-37.4%)
vs Peers
vs Industry
Below avg
CTNM financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
29.1
▲
765%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
-0.1
▼
115%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
CTNM fundamentals radar
CTNM
Peer median
Industry
CTNM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CTNM vs peers: key metrics
Latest News
No related news yet